The U.S. Supreme Court’s decision Monday to put restrictions on where patent lawsuits can be filed will limit the ability of patent owners to file cases in favorable courts, likely marking the end of the Eastern District of Texas as a patent litigation hot spot. Here, Law360 takes a look at the impact and other possible fallout from the ruling.
A Spanish court has ruled in favor of a unit of Bentley Pharmaceuticals, dealing Merck & Co. another blow in its attempt to protect its anti-cholesterol blockbuster drug Zocor from generic protection in Spain.
The European Commission is considering legislation that would regulate and streamline copyright royalty collection across Europe, the European Union’s executive body said Monday.
A U.S. District Court jury in Connecticut has determined that MJ Research infringed four patents held by a unit of genetic equipment maker Applera Corp.
A Filipino court has handed local drug maker United Laboratories Inc. a legal win in its patent battle with U.K.-Swedish drug giant AstraZeneca over a hypertension drug.
Bay area intellectual property specialty firm Fernandez & Associates has established a technology licensing advisory group to consult universities and emerging high-tech companies on their licensing options.
EchoStar Communications has asked a judge to transfer the patent lawsuit filed against the satellite television provider by TiVo, a vendor of digital video recorders, from Texas to California, a regulatory filing shows.
National law firm Morgan Lewis has hired Jeffry S. Mann from intellectual property specialist firm Townsend & Townsend & Crew to join its life sciences patent practice as a partner.
A public advocacy group has challenged the patent for Microsoft’s computer file format system at the U.S. Patent and Trademark Office.
Microscope vendor Applied Imaging has filed a motion in U.S. District Court for the Southern District of California to transfer the pending patent infringement litigation filed by rival ChromaVision Medical Systems to Northern California.
In the first significant trademark dispute in the fast-growing low-carb diet market, Abbott Laboratories’ ZonePerfect Nutrition Co. has filed a lawsuit against Hershey Foods, claiming that Hershey’s forthcoming “Smartzone” nutrition bar infringes on ZonePerfect's trademarks.
Shanghai will unveil plans next week to open an intellectual property rights facility designed to offer comprehensive regulatory services.
Indian drug maker Dr. Reddy’s has filed a manufacturing application with the U.S. Food and Drug Administration for a generic version of U.K.-Swedish pharmaceutical giant AstraZeneca’s schizophrenia drug Seroquel.
Dutch conglomerate company Akzo Nobel and its subsidiary Organon USA have agreed to pay $28 million to settle an antitrust suit brought by three generic drug makers over the company’s patent infringement suits regarding the antidepressant Remeron.
Lindows, which is being sued for trademark infringement by Microsoft, has changed its product name to Linspire, the company said.
A conference designed to follow up on the Federal Trade Commission’s recommendations for sweeping reforms to the U.S. patent system is expected to draw some of the country’s most influential scholars, industry leaders and policy makers this week.
National law firm Piper Rudnick has hired patent attorney Dale Lazar from Pillsbury Winthrop to practice as a partner in the firm’s Northern Virginia office.
The United States is planning to put Israel on its priority watch list of countries that violate intellectual property rights, an Israeli business paper is reporting.
The U.S. International Trade Commission is expected to ban imports of display controllers manufactured by Mstar Semiconductor after determining that the Taiwanese chip maker infringes a patent held by rival Genesis Microchip.
More than two years after China granted patent exclusivity for Pfizer’s Viagra anti-impotence drug, an onslaught of patent challenges has left the drug’s status in limbo, officials at China’s State Intellectual Property Office (SIPO) have conceded.
Indian pharmaceutical companies have urged the government to pass legislation on data protection exclusivity.